Cited by 117Heart rate and cardiovascular healthDiabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk Factors

Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus

Open access
Hillis, G. S., Woodward, M., Rodgers, A., Chow, C. K., Li, Q., Zoungas, S., Patel, A., Webster, R. +5 more·2012·Diabetologia

Abstract

Aims/hypothesis An association between resting heart rate and mortality has been described in the general population and in patients with cardiovascular disease. There are, however, few data exploring this relationship in patients with type 2 diabetes mellitus. The current study addresses this issue.Methods The relationship between baseline resting heart rate and all-cause mortality, cardiovascular death and major cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) was examined in 11,140 patients who participated in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) Study.Results A higher resting heart rate was associated with a significantly increased risk of all-cause mortality (fully adjusted HR 1.15 per 10 bpm [95% CI 1.08, 1.21], p<0.001), cardiovascular death and major cardiovascular outcomes without adjustment and after adjusting for age and sex and multiple covariates. The increased risk associated with a higher baseline resting heart rate was most obvious in patients with previous macrovascular complications (fully adjusted HR for death 1.79 for upper [mean 91 bpm] vs lowest [mean 58 bpm] fifth of resting heart rate in this subgroup [95% CI 1.28, 2.50], p = .001).Conclusions/interpretation Among patients with type 2 diabetes, a higher resting heart rate is associated with an increased risk of death and cardiovascular complications. It remains unclear whether a higher heart rate directly mediates the increased risk or is a marker for other factors that determine a poor outcome.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-012-2471-y

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hillis, G. S., Woodward, M., Rodgers, A., Chow, C. K., Li, Q., Zoungas, S., Patel, A., Webster, R., Batty, G. D., Ninomiya, T., Mancia, G., Poulter, N. R., & Chalmers, J.
Affiliations
  • Royal Prince Alfred Hospital (AU)
  • University College London (GB)
  • Kyushu University (JP)
  • University of Milano-Bicocca (IT)
  • Imperial College London (GB)
Corresponding author
Hillis, G. S.
Venue
Diabetologia
Published
2012-01-29
Volume
55
Issue
5
Pages
1283-1290
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2153546653
Cited by
117
References
43
Citations by year
2026: 2 · 2025: 11 · 2024: 9 · 2023: 12 · 2022: 3 · 2021: 11 · 2020: 9 · 2019: 13 · 2018: 8 · 2017: 7 · 2016: 11 · 2015: 5 · 2014: 7 · 2013: 5 · 2012: 4
FWCI
4.32
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • Wellcome Trust (081021)
  • Servier
  • Medical Research Council
  • National Health and Medical Research Council (211086, 358395)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
resting heart rate, type 2 diabetes, all-cause mortality, cardiovascular mortality, cardiovascular complications, myocardial infarction, stroke, macrovascular complications, ADVANCE trial, cardiovascular risk markers
MeSH terms
Aged, Cardiovascular Diseases, Cause of Death, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Female, Heart Rate, Humans, Male, Middle Aged, Myocardial Infarction, Risk, Stroke, Microvessels, Diabetic Cardiomyopathies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review